Shilpa Drug Patent Portfolio

Shilpa owns 2 orange book drugs protected by 5 US patents Given below is the list of Shilpa's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11147817 Pharmaceutical composition of pemetrexed 26 Mar, 2035
Active
US8940786 Non-aqueous taxane nanodispersion formulations and methods of using the same 30 Sep, 2033
Active
US9308195 Non-aqueous taxane formulations and methods of using the same 30 Sep, 2033
Active
US9763880 Non-aqueous taxane formulations and methods of using the same 30 Sep, 2033
Active
US10842770 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same 07 Aug, 2031
Active


Given below is the list of recent legal activities going on the following drug patents of Shilpa.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 08 May, 2024 US10842770
Payment of Maintenance Fee, 8th Year, Large Entity 27 Sep, 2023 US9308195
Payment of Maintenance Fee, 8th Year, Large Entity 13 Jul, 2022 US8940786
Recordation of Patent Grant Mailed 19 Oct, 2021 US11147817
Patent Issue Date Used in PTA Calculation 19 Oct, 2021 US11147817
Email Notification 30 Sep, 2021 US11147817
Issue Notification Mailed 29 Sep, 2021 US11147817
Application Is Considered Ready for Issue 22 Sep, 2021 US11147817
Dispatch to FDC 22 Sep, 2021 US11147817
Issue Fee Payment Verified 20 Sep, 2021 US11147817
Issue Fee Payment Received 20 Sep, 2021 US11147817
Mail Notice of Allowance 01 Jul, 2021 US11147817
Email Notification 01 Jul, 2021 US11147817
Electronic Review 01 Jul, 2021 US11147817
Notice of Allowance Data Verification Completed 29 Jun, 2021 US11147817


Shilpa's Family Patents

Shilpa drugs have patent protection in a total of 26 countries. It's US patent count contributes only to 20.4% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Shilpa Drug List

Given below is the complete list of Shilpa's drugs and the patents protecting them.


1. Docetaxel

Docetaxel is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8940786 Non-aqueous taxane nanodispersion formulations and methods of using the same 30 Sep, 2033
(8 years from now)
Active
US9308195 Non-aqueous taxane formulations and methods of using the same 30 Sep, 2033
(8 years from now)
Active
US9763880 Non-aqueous taxane formulations and methods of using the same 30 Sep, 2033
(8 years from now)
Active
US10842770 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same 07 Aug, 2031
(6 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Docetaxel's drug page


2. Pemetrexed

Pemetrexed is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11147817 Pharmaceutical composition of pemetrexed 26 Mar, 2035
(10 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pemetrexed's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List